Search Results

Alamar Biosciences (Alamar), and Mologic, Ltd. (Mologic), today announced a collaboration to utilize Alamar’s novel antibodies against SARS-CoV-2 Nucleocapsid (N) protein for Mologic’s future COVID-19 RDTs.

Collaboration facilitated by the Bill & Melinda Gates Foundation through an expansion of an existing grant to Mologic

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has completed the latest phase of the Company’s expansion plans.

Partnership to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing in low and middle income countries

Mologic Ltd announced that it has finished recruitment to a major clinical trial with University College London Hospitals (UCLH) to evaluate the Company’s point-of-care (POC) diagnostic test for the early detection of sepsis.

Mologic Ltd announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®.

Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has commenced a clinical trial to evaluate the Company’s urine-based diagnostic, HeadsUp, in monitoring pulmonary exacerbation in cystic fibrosis (CF) patients.

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has completed the development of a next generation ultra-sensitive lateral flow-based technology platform. Initially being exemplified through the development of low cost, high performance devices for malaria and HIV, the novel diagnostics can be visually read and demonstrate up to a 1,000-fold improvement in sensitivity over current technology.

Grant awarded by the Wellcome Trust and DFID, as part of UK government’s £46 million international COVID-19 prevention and research package

Observational, multi-centre validation trial carried out in collaboration with a consortium of leading clinicians and clinical centres